相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation
Eun Ji Lee et al.
FASEB JOURNAL (2015)
HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients
JooYeon Jhun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats
Cuiping Fu et al.
SLEEP AND BREATHING (2015)
Glycyrrhizic Acid Ameliorates HMGB1-Mediated Cell Death and Inflammation after Renal Ischemia Reperfusion Injury
Arthur Lau et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Sleep Apnea and the Kidney Is Sleep Apnea a Risk Factor for Chronic Kidney Disease?
Patrick J. Hanly et al.
CHEST (2014)
Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression
Zhiyong Shi et al.
INFLAMMATION RESEARCH (2014)
Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease
Eun Young Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Role of high mobility group box 1 and its signaling pathways in renal diseases
Tian-Biao Zhou
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2014)
Protective Effect of Glycyrrhizin, a Direct HMGB1 Inhibitor, on Focal Cerebral Ischemia/Reperfusion-Induced Inflammation, Oxidative Stress, and Apoptosis in Rats
Gu Gong et al.
PLOS ONE (2014)
The Proinflammatory RAGE/NF-kappa B Pathway Is Involved in Neuronal Damage and Reactive Gliosis in a Model of Sleep Apnea by Intermittent Hypoxia
Maria Florencia Angelo et al.
PLOS ONE (2014)
Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic hypoxia in the mouse
David G. S. Farmer et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis
Rossana G. Iannitti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma
Chen-Chen Lee et al.
BIOCHEMICAL PHARMACOLOGY (2013)
High mobility group box 1 and kidney diseases (Review)
Ping Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
Gurdip Daffu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation
Marion A. Hofmann Bowman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
Caixia Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease
Yu-Shi Bao et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Clinical Presentation of Obstructive Sleep Apnea in Patients with Chronic Kidney Disease
David D. M. Nicholl et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2012)
Serum S100B protein: a useful marker in obstructive sleep apnea syndrome
Serap Duru et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2012)
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)
D. Leonardis et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
Eitan M. Akirav et al.
PLOS ONE (2012)
Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway
Geum-Youn Gwak et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling
Alejandro Villarreal et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Neutralization of the extracellular HMGB1 released by ischaemic-damaged renal cells protects against renal ischaemia-reperfusion injury
Junhua Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effects of Specific Genes Activating RAGE on Polycystic Kidney Disease
Eun Young Park et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Effect of Treatment by Nasal Continuous Positive Airway Pressure on Serum High Mobility Group Box-1 Protein in Obstructive Sleep Apnea
Kun-Ming Wu et al.
CHEST (2010)
High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy
Yoko Oyama et al.
LABORATORY INVESTIGATION (2010)
RAGE and the pathogenesis of chronic kidney disease
Vivette D'Agati et al.
NATURE REVIEWS NEPHROLOGY (2010)
Sleep Apnea in Early and Advanced Chronic Kidney Disease Kaiser Permanente Southern California Cohort
John J. Sim et al.
CHEST (2009)
Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients
Kuang-Hsing Chiang et al.
CORONARY ARTERY DISEASE (2009)
Soluble forms of RAGE in internal medicine
Natale Vazzana et al.
INTERNAL AND EMERGENCY MEDICINE (2009)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
Annette Bruchfeld et al.
MOLECULAR MEDICINE (2008)
Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia
Paola Pichiule et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High mobility group box I protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo
G. Faraco et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Receptor for advanced glycation end products -: soluble form and gene polymorphisms in chronic haemodialysis patients
Marta Kalousova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid
Weiwen Jiang et al.
JOURNAL OF IMMUNOLOGY (2007)
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
Jung-Bin Kim et al.
JOURNAL OF NEUROSCIENCE (2006)
Bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores
EZ Bagci et al.
BIOPHYSICAL JOURNAL (2006)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both
A Nakao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
L Adhikary et al.
DIABETOLOGIA (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
D Stern et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Advanced glycosylation end products induce NF-κB dependent NOS expression in RAW 264.7 cells
CH Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)
The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells
MJ Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
U Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
分享论文
